Remote Tracking of Epilepsy Patients
The investigators propose a novel method for tracking the seizure frequency, side effect burden, and medication compliance for patients with epilepsy. The investigators intend to utilize a table-top device currently for tracking other chronic disease to collect remote data from epilepsy patients. The hypothesis is that the use of this device will lead to better longterm treatment outcomes than the standard outpatient mechanism of following patients longitudinally.
|Official Title:||Pilot Study of Real-time Automated Tracking System for Patients With Epilepsy|
- Seizure frequency per month [ Time Frame: 1 year ] [ Designated as safety issue: No ]Assessment of seizure count accuracy by assessing total number of seizures reported per month
- Medication compliance [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]Assessment of compliance with taking medications at regularly scheduled intervals
- Quality of life [ Time Frame: 1 year ] [ Designated as safety issue: No ]Quality of Life in Epilepsy inventory, to assess for overall change in quality of life measures
|Study Start Date:||July 2010|
|Estimated Study Completion Date:||July 2013|
|Estimated Primary Completion Date:||July 2011 (Final data collection date for primary outcome measure)|
Epilepsy patients, electronic diary
Cohort of epilepsy patient using an electronic diary system to record all seizures, side effects, and medication compliance
Noninvasive device for remotely reporting health information. The device does nothing to change the health of the patient, but transmits health data that is entered by the patient directly to the physician's office. Patients will enter data on seizure frequency, medication compliance, and side effects.
Other Name: Healthbuddy is a product of Bosch Healthcare, and is already utilized in many medical institutions around the country, including the VA Health System.
Epilpesy patient, no electronic diary
Group of epilepsy patients who are followed using the standard of care, which is a paper diary and routine outpatient follow up visits
Please refer to this study by its ClinicalTrials.gov identifier: NCT01130649
|United States, California|
|Univ of California San Fran|
|San Francisco, California, United States, 94143|
|Principal Investigator:||John Hixson, MD||University of California, San Francisco|